Thursday, January 23, 2014

Prepare for 340B Program Changes and the AMP Final Rule the clock ticks down on the few months left before the AMP Final Rule is released, IIR's 6th Annual Government Programs Summit in March will be your last opportunity to hear from colleagues who have prepared for the impact of each individual component of the rule:

This full day panel discussion will prepare for the individual components of the Final Rule and also address the combined GP and Finance concerns that manufacturers are facing for planning and forecasting. Because Q2 publication of the long-awaited CMS AMP Final Rule will have a financial impact and affect forecasting, gross-to-net, and accruals, it is no longer exclusively a GP issue and is just as important for a company's Finance organization to prepare for the changes.

Jennifer Norton, Senior Director, Pricing & Contract Administration - Managed Markets, Vertex Pharmaceuticals
Sabrina Yohai, Senior Corporate Counsel, Pfizer
Michael Hepburn, Sr. Director, Government Contract Compliance, Janssen Pharmaceuticals

CIS Speakers:
Chris Cobourn, Senior Vice President, Commercial Compliance
Erika Scholl, Senior Manager, Government Programs Consulting
Tom Evegan, Commercial Contracting Services

340B Summit for Manufacturers - In collaboration with Apexus' 340 University

The 340B universe is changing and this means various things for manufacturers. There is increased scrutiny as to the level of 340B compliance for all stakeholders, including manufacturers' compliance with pricing as well as covered entities' compliance with program requirements. OPA has begun publishing audit results from 340B covered entities, promising crucial information on covered entities' compliance with the program. Get access to the experts in an interactive session tailored for manufacturers. Learn the latest in these key hot topic areas: Orphan Drugs, GPO Prohibition, Covered Outpatient Drugs, Audits, and more!

Cmdr. Krista M. Pedley, PharmD, MS, CDR, USPHS, Director, Office of Pharmacy Affairs, Health Resources and Services Administration
Christopher Hatwig, MS, RPh, FASHP, President, Apexus, 340B Prime Vendor Program
Larry Stepp, Vice President, National Accounts, AmerisourceBergen
Perry Knight, Senior Counsel, Johnson & Johnson
Robert Nahoopii, PharmD, MS, BCPS, CEO/Co-Founder, Turnkey Pharmacy Solutions, A 340B Management Company

To learn more, download our agenda.

Register with code XP1951BLOG by this Friday (1/24) and receive up to $400 off of the standard rate. If you have any questions about the event, feel free to contact Kate Devery ( For more information visit our homepage. We hope to see this March!

The Government Programs Team

Opt-in for GP updates
GP Twitter

No comments: